Chief of Endocrine Section, VANCHCS Professor of Medicine, UC Davis
Endocrinology
Dr. Arthur L. Swislocki, MD
|
|
Give Review
Arthur Swislocki works in the field of Endocrinology. He researched medicine at David Geffen School of Medicine at UCLA. David Geffen School of Medicine at UCLA is a top medical university. David Geffen School of Medicine at UCLA is ranked 13/7 in Research/PrimaryCare. Doctor Arthur L. Swislocki, MD is a published doctor. He has 71 papers published. The most current publication "Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention Study." Arthur L. Swislocki accepts all Medicare patients.
Publications
- Comparing Fracture Absolute Risk Assessment (FARA) Tools: An Osteoporosis Clinical Informatics Tool to Improve Identification and Care of Men at High Risk of First Fra...
- HbA1c and Metabolic Syndrome.
- Plasma testosterone is associated With Framingham risk score.
- Secretin-stimulated amylase release into blood is impaired in type 1 Diabetes mellitus.
- Blood pressure control in a diabetic population assessed by computer review.
- Adoption of a new technology in a Veterans Affairs national formulary system With local implementation: the insulin glargine example.
- The stumble-from pipe cleaner to bone builder.
- The effect of body mass index on fasting blood glucose after initiation of thiazide therapy in hypertensive patients.
- Effects of antihypertensives on glucose metabolism.
- Acarbose attenuates Basal and postprandial insulin concentrations but fails to lower blood pressure in the spontaneously hypertensive rat.
- Computer-based screening of chest X-rays for vertebral compression fractures as an Osteoporosis index in men.
- Correction.
- Smokeless nicotine exposure has no lasting effect on fasting or postglucose circulation leptin in young rats.
- Computer confirmation of improved blood pressure control in diabetic patients.
- Computer-based screening of veterans for metabolic Syndrome.
- A randomized clinical trial of the effectiveness of photon stimulation on pain, sensation, and quality of life in patients With diabetic peripheral neuropathy.
- The effect of body mass index on fasting blood glucose and development of Diabetes mellitus after initiation of extended-release niacin.
- Hypertensive treatment in patients With metabolic syndrome.
- Prevalence of Osteoporosis in men in a VA rehabilitation center.
- The ACCORD Study: the devil is in the details.
- Resistant hypertension and undiagnosed primary hyperaldosteronism detected by use of a computerized database.
- Long-term maintenance of glucose control in veterans with type 2 Diabetes mellitus using oral agents.
- Docosahexaenoic Acid supplementation improved lipocentric but not glucocentric markers of insulin sensitivity in hypertriglyceridemic men.
- Pharmacotherapy for the Metabolic Syndrome.
- Hypothalamic-Pituitary-AdRenal Suppression and Iatrogenic Cushing's Syndrome as a Complication of Epidural Steroid Injections.
- Insulin syringe disposal patterns at a VA hospital.
- High density lipoprotein turnover in patients With hypertension.
- Workshop III--Insulin resistance: is it truly the link?
- Comparison of the effects of atenolol and nifedipine on glucose, insulin, and lipid metabolism in patients With hypertension.
- Effect of prazosin treatment on HDL kinetics in patients With hypertension.
- Insulin resistance and hypertension.
- McCune-Albright Syndrome. A case of primary hypogonadism obscured by hyperprolactinemic hypogonadotropic hypogonadism.
- California living II: not-the-big-one had no effect on blood pressure.
- Persistence of hypertriglyceridemic effect of low-fat high-carbohydrate diets in NIDDM patients.
- Responsiveness of superficial hand veins to phenylephrine in essential hypertension. Alpha adrenergic blockade during prazosin therapy.
- Effect of prazosin treatment on carbohydrate and lipoprotein metabolism in patients With hypertension.
- Insulin resistance, glucose intolerance and hyperinsulinemia in patients With hypertension.
- Effect of enprostil on plasma glucose, insulin and lipid metabolism in patients with non-insulin-dependent Diabetes mellitus.
- Effect of time on measurement of hepatic glucose production.
- Relationships between plasma-free fatty acid concentration, endogenous glucose production, and fasting hyperglycemia in normal and non-insulin-dependent diabetic indiv...
- Effect of source of dietary carbohydrate on plasma glucose and insulin responses to mixed meals in subjects With NIDDM.
- Insulin suppression of plasma-free fatty acid concentration in normal individuals and patients with type 2 (non-insulin-dependent) Diabetes.
- Improved insulin action in muscle, liver, and adipose tissue in physically trained human subjects.
- Effect of obesity on ambient plasma glucose, free fatty acid, insulin, Growth hormone, and glucagon concentrations.
- Documentation of hyperglucagonemia throughout the day in nonobese and obese patients with noninsulin-dependent Diabetes mellitus.
- Deleterious metabolic effects of high-carbohydrate, sucrose-containing diets in patients with non-insulin-dependent Diabetes mellitus.
- Can insulin resistance exist as a primary defect in noninsulin-dependent Diabetes mellitus?
- Resistance to insulin suppression of plasma free fatty acid concentrations and insulin stimulation of glucose uptake in noninsulin-dependent Diabetes mellitus.
- Ambient plasma free fatty acid concentrations in noninsulin-dependent Diabetes mellitus: evidence for insulin resistance.
- Impaired insulin clearance in essential hypertension.
- Glucose tolerance and blood pressure are improved in the spontaneously hypertensive rat by ethyl-2-(6-(4-chlorophenoxy)-hexyl)oxirane-2-carboxylate (etomoxir), an inhi...
- Insulin resistance and hypertension: glucose intolerance, hyperinsulinemia, and elevated free fatty acids in the lean spontaneously hypertensive rat.
- Microalbuminuria in a normotensive insulin-treated diabetic population.
- Estradiol stimulates cortisol production by adRenal cells in estrogen-dependent primary adrenocortical nodular dysplasia.
- Acute metabolic effects of clonidine and adenosine in man.
- Oral administration of the nitric oxide biosynthesis inhibitor, N-nitro-L-arginine methyl ester (L-NAME), causes hypertension, but not glucose intolerance or insulin r...
- Smokeless nicotine administration is associated With hypertension but not With a deterioration in glucose tolerance in rats.
- Insulin resistance and hypertension: in vivo and in vitro insulin action in skeletal muscle in spontaneously hypertensive and Wistar-Kyoto rats.
- Hyperthyroidism: an underappreciated cause of diffuse bone Disease.
- Case report. Pseudohepatotoxicity of metformin.
- Coronary events With lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention Study.
- Postmarketing analysis of lovastatin use in the VA Northern California System of Clinics: a retrospective, computer-based study.
- Safety and efficacy of metformin in a restricted formulary.
- Metabolic, hemodynamic, and cardiac effects of captopril in young, spontaneously hypertensive rats.
- Pioglitazone attenuates basal and postprandial insulin concentrations and blood pressure in the spontaneously hypertensive rat.
- Renal effects of angiotensin-converting enzyme inhibitors that result in cost savings and improved patient outcomes.
- Voluntary running improves glucose tolerance and insulin resistance in female spontaneously hypertensive rats.
- Reduction in self-monitoring of blood glucose in persons with type 2 Diabetes results in cost savings and no change in glycemic control.
- Effects of ovariectomy on indices of insulin resistance, hypertension, and cardiac energy metabolism in middle-aged spontaneously hypertensive rats (SHR).
- Smokeless nicotine administration does not result in hypertension or a deterioration in glucose tolerance or insulin sensitivity in juvenile rats.
Schools
David Geffen School Of Medicine At UCLA University Of California Los Angeles
Los Angeles County University Of California Med Center
University Calif Davis Med Center
Stanford
Conditions Treated
- Diabetes Type 1
- Diabetes Type 2
- Diabetes With Renal Manifestations
- Goiter
- View All
Doctors Specialties
- Endocrinology
Accepted Insurances
Education
-
University of California Davis -
University of Southern California - LAC+USC Medical Center -
David Geffen School of Medicine at UCLA
Hospital
-
University of California, Davis Medical Center
Drug Facts
| NPI NUMBER | 1043294705 | |
| NPPES Provider LastName | SWISLOCKI | |
| NPPES Provider FirstName | ARTHUR | |
| NPPES Provider ZIPCode | 945534668 | |
| NPPES Provider State | CA | |
| Specialty Description | Endocrinology | |
| Total Claim Count | 95.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1043294705 |
| Last Name Of The Provider | SWISLOCKI |
| First Name Of The Provider | ARTHUR |
| View All |
Similar Doctors
|
|
Dr. Robert H. Noth, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yih Chang, MD
This Doctor is OpenDoctor Recommended.
|
|
Jamie Coughlan, CANP |